BIOMAT Database Logo BIOMAT Database Logo

Fulminant hepatic failure after 2'-deoxycoformycin (pentostatin) 1999

M Sanchez, and M Orero, and J Marco, and J Simón, and M Linares, and F Carbonell

UI MeSH Term Description Entries
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D015649 Pentostatin A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity. 2'-Deoxycoformycin,CI-825,Co-Vidarabine,Deoxycoformycin,Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-,NSC-218321,Nipent,2' Deoxycoformycin,CI 825,CI825,NSC 218321,NSC218321
D016399 Lymphoma, T-Cell A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes. T-Cell Lymphoma,Lymphoma, T Cell,Lymphomas, T-Cell,T Cell Lymphoma,T-Cell Lymphomas
D017114 Liver Failure, Acute A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C. Acute Hepatic Failure,Fulminant Hepatic Failure,Fulminating Hepatic Failure,Hepatic Failure, Fulminant,Liver Failure, Fulminant,Acute Liver Failure,Fulminating Liver Failure,Hepatic Failure, Acute,Failure, Acute Hepatic,Failure, Acute Liver,Fulminant Hepatic Failures,Fulminant Liver Failure,Fulminant Liver Failures,Fulminating Hepatic Failures,Fulminating Liver Failures,Hepatic Failure, Fulminating,Liver Failure, Fulminating
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

M Sanchez, and M Orero, and J Marco, and J Simón, and M Linares, and F Carbonell
Response of Waldenstrom's macroglobulinemia to pentostatin (2'-deoxycoformycin).
April 1986, Cancer treatment reports,
M Sanchez, and M Orero, and J Marco, and J Simón, and M Linares, and F Carbonell
Refractory Hodgkin lymphoma responds to pentostatin (2'-deoxycoformycin).
February 2006, Leukemia & lymphoma,
M Sanchez, and M Orero, and J Marco, and J Simón, and M Linares, and F Carbonell
Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).
April 1987, The New England journal of medicine,
M Sanchez, and M Orero, and J Marco, and J Simón, and M Linares, and F Carbonell
Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
January 1989, Bone marrow transplantation,
M Sanchez, and M Orero, and J Marco, and J Simón, and M Linares, and F Carbonell
Effectiveness of pentostatin (2'-deoxycoformycin) in refractory lymphoid neoplasms.
February 1984, Scandinavian journal of haematology,
M Sanchez, and M Orero, and J Marco, and J Simón, and M Linares, and F Carbonell
Pentostatin (2'-deoxycoformycin) for the treatment of lymphoid neoplasms.
September 1990, Cancer treatment reviews,
M Sanchez, and M Orero, and J Marco, and J Simón, and M Linares, and F Carbonell
Fulminant hepatic failure after occupational exposure to 2-nitropropane.
October 1987, Annals of internal medicine,
M Sanchez, and M Orero, and J Marco, and J Simón, and M Linares, and F Carbonell
Immunosuppressive effect of 2'-deoxycoformycin (Pentostatin) for rat islet allotransplantation.
January 1995, Cell transplantation,
M Sanchez, and M Orero, and J Marco, and J Simón, and M Linares, and F Carbonell
Treatment of cutaneous T cell lymphoma with 2'-deoxycoformycin (pentostatin).
October 1988, Journal of the American Academy of Dermatology,
M Sanchez, and M Orero, and J Marco, and J Simón, and M Linares, and F Carbonell
Developmental toxicity of pentostatin (2'-deoxycoformycin) in rats and rabbits.
September 1991, Teratology,
Copied contents to your clipboard!